In this patient story, Giles shares his skin health journey through the decades and how he felt when a suspicious lump on his left temple led him to experience AI for skin cancer detection.
Clinical AI Lead at Skin Analytics, Dr Dilraj Kalsi presented how DERM is at least as good as dermatologists at safely ruling out melanoma at the American Academy of Dermatology
Skin Analytics has secured £15 million in Series B funding led by Intrepid Growth Partners.
Dr Alice Plant, Consultant Dermatologist at University Hospitals Dorset NHS Foundation Trust, and Dr Dilraj Kalsi, Clinical AI Lead at Skin Analytics joined Future Medicine AI Hub to discuss how AI is proving to transform NHS dermatology services.
Register for this HSJ webinar to hear how primary and secondary care organisations across Suffolk and North East Essex ICB worked in partnership to deploy DERM.
From sceptic to strong supporter: why I believe everyone should have access to AI skin cancer assessments.
Following the implementation of DERM, Kingston and Richmond NHS Foundation Trust have been shortlisted for two HTN awards – Best use of AI for diagnosis, treatment and patient care & AI Solution of the Year.
Bolton NHS Foundation Trust are the next Trust in Greater Manchester to deploy DERM into their urgent suspected skin cancer pathway.
In this personal account, Stevan shares his experience of AI for skin cancer detection following extensive exposure to the sun during time in the Service and mountaineering.
The Times reports on Chelsea and Westminster Hospital NHS Foundation Trust deploying DERM autonomously, marking a new era for cancer care.
Skin Analytics and Chelsea and Westminster Hospital NHS Foundation Trust win the HSJ Partnership Award 2025 for Most Effective Contribution to Improving Cancer Outcomes.
The Class III CE marking under the European Medical Device Regulation (MDR) 2017/745 reflects the highest level of regulatory scrutiny and underlines DERM’s safety, accuracy and effectiveness in detecting cancer in patients without clinician review. al decisions on skin cancer without oversight marking a transformative era for global healthcare.
In this personal account, Jess shares her experience of the Skin Analytics pathway, what happened after she noticed a lump that had changed and how she felt about AI assessing her skin lesion.
This webinar will showcase real NHS stories and expert insights into how AI as a Medical Device (AIaMD) is transforming dermatology waitlists, improving patient outcomes, and delivering measurable value across trusts.
Hear from NHS colleagues at Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) about how they’re using DERM, the world’s first autonomous AIaMD for dermatology.
In this week’s episode of The Scrubbed In Show podcast, our CEO Neil Daly shares his journey from consulting into building Skin Analytics.
Our longstanding NHS partner, Chelsea and Westminster Hospital NHS Foundation Trust, are now deploying DERM to identify and discharge patients with benign lesions, without validation from their dermatology team.
We’re delighted to be finalists for FIVE 2025 HSJ Partnership Awards alongside our NHS partners.
West Middlesex University Hospital, part of Chelsea and Westminster Hospital NHS Foundation Trust, are set to deliver a post-referral service for suspected skin cancer using AI Teledermatology.
Session recording now available to watch! At this year’s NHS Providers Conference, NHS University Hospitals of Liverpool Group shared value seen, learnings and future plans following the implementation of DERM.
Last night we joined our partners, NHS Suffolk and North East Essex Integrated Care Board and Chelsea and Westminster Hospital NHS Foundation Trust to celebrate their nominations at the HSJ Awards 2024.
Another NHS partnership! But this time with HMR in primary care! HMR will leverage AI-driven teledermatology to discharge patients with benign lesions earlier in the
We’re thrilled to share that Skin Analytics has been awarded a place on the G-Cloud 14 Framework, one of the UK government’s leading procurement frameworks for cloud software and services.
The BMA recently published their principles for Artificial Intelligence (AI) and its application in healthcare, so we thought this provides a great opportunity for us to share how we have implemented them at Skin Analytics over the last 5 years.
The Northern Cancer Alliance launches an AI-driven post-referral service for suspected skin cancer with Skin Analytics in Stockport, Bury and Salford.
In a recent article from L’Atelier BNP Paribas, Alex Hadwick breaks down the quiet breakthrough of vision AI, and what the future looks like through its lenses.
Skin Analytics and University Hospitals Dorset NHS Foundation Trust share how the Trust implemented DERM to address rising urgent suspected skin cancer referrals, finite dermatology capacity and a patient population with high incidence rates of skin cancer.
Bloomberg canvassed the UK to find 25 startups to watch and Skin Analytics featured in list!
NICE EVA initial draft guidance: Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway We have seen
Mentioning the work we’re doing here at Skin Analytics with the NHS, Streeting went on to say, ‘Reform is not just possible, it is happening. From AI detecting skin cancer and cutting waiting times to weight loss jabs slashing the risk of heart attacks for diabetes patients.’
Professor Lord Darzi’s latest report is confronting. But here is why our CEO, Neil Daly is optimistic about what it means for our NHS.
